Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teru Hideshima

Showing results (11-20 of 300) with videos related to

Pageof 30
Sort By:
Blood Reviews|December 4, 2010
Multiple myeloma: biology of the diseaseAnuj Mahindra, Teru Hideshima, Kenneth C Anderson
International Journal of Hematology|April 22, 2016
Histone deacetylase inhibitors in multiple myeloma: from bench to bedsideTakeshi Harada, Teru Hideshima, Kenneth C Anderson
British Journal of Haematology|December 21, 2002
Novel therapies for multiple myelomaToshiaki Hayashi, Teru Hideshima, Kenneth C Anderson
Leukemia & Lymphoma|December 16, 2006
Non-steroidal anti-inflammatory drug therapy for chronic lymphocytic leukemiaHiroshi Yasui, Teru Hideshima, Kenneth C Anderson
Blood Cancer Journal|September 8, 2018
The biological significance of histone modifiers in multiple myeloma: clinical applicationsHiroto Ohguchi, Teru Hideshima, Kenneth C Anderson
Reviews in Clinical and Experimental Hematology|March 6, 2003
Novel biologically based therapeutic strategies in myelomaDeepak Gupta, Teru Hideshima, Kenneth C Anderson
Expert Review of Anticancer Therapy|October 6, 2006
Therapeutic use of immunomodulatory drugs in the treatment of multiple myelomaNoopur Raje, Teru Hideshima, Kenneth C Anderson
Advances in Experimental Medicine and Biology|April 29, 2008
Targeting proteasomes as therapy in multiple myelomaDharminder Chauhan, Teru Hideshima, Kenneth C Anderson
Blood Cancer Journal|October 7, 2021
Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applicationsHiroto Ohguchi, Teru Hideshima, Kenneth C Anderson
Experimental Hematology|June 30, 2015
Novel therapeutic strategies for multiple myelomaNaoya Mimura, Teru Hideshima, Kenneth C Anderson
Pageof 30

Showing results (11-20 of 300) with videos related to

Sort By:
Pageof 30
Blood Reviews|December 4, 2010
Multiple myeloma: biology of the diseaseAnuj Mahindra, Teru Hideshima, Kenneth C Anderson
International Journal of Hematology|April 22, 2016
Histone deacetylase inhibitors in multiple myeloma: from bench to bedsideTakeshi Harada, Teru Hideshima, Kenneth C Anderson
British Journal of Haematology|December 21, 2002
Novel therapies for multiple myelomaToshiaki Hayashi, Teru Hideshima, Kenneth C Anderson
Leukemia & Lymphoma|December 16, 2006
Non-steroidal anti-inflammatory drug therapy for chronic lymphocytic leukemiaHiroshi Yasui, Teru Hideshima, Kenneth C Anderson
Blood Cancer Journal|September 8, 2018
The biological significance of histone modifiers in multiple myeloma: clinical applicationsHiroto Ohguchi, Teru Hideshima, Kenneth C Anderson
Reviews in Clinical and Experimental Hematology|March 6, 2003
Novel biologically based therapeutic strategies in myelomaDeepak Gupta, Teru Hideshima, Kenneth C Anderson
Expert Review of Anticancer Therapy|October 6, 2006
Therapeutic use of immunomodulatory drugs in the treatment of multiple myelomaNoopur Raje, Teru Hideshima, Kenneth C Anderson
Advances in Experimental Medicine and Biology|April 29, 2008
Targeting proteasomes as therapy in multiple myelomaDharminder Chauhan, Teru Hideshima, Kenneth C Anderson
Blood Cancer Journal|October 7, 2021
Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applicationsHiroto Ohguchi, Teru Hideshima, Kenneth C Anderson
Experimental Hematology|June 30, 2015
Novel therapeutic strategies for multiple myelomaNaoya Mimura, Teru Hideshima, Kenneth C Anderson
Pageof 30